(PRBuzz.com) May 17, 2013 -- Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). The company's flagship product is an endoluminal stent graft and accompanying delivery system, for the treatment of AAA, a weakening of the wall of the aorta which is the largest artery of the body. The company sells its ELG system to hospitals in the US, Europe, and to third-party international distributors. The company has manufacturing facility in Irvine. Endologix is headquartered in California, the US.